This inventor holds 1 USPTO granted patent. Top assignee: Molecular Templates, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Lei Shen - Innovator in Cancer Therapy
Introduction
Lei Shen is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of cancer therapy through her innovative research and development. Her work focuses on predictive biomarkers that can enhance the effectiveness of cancer treatments.
Latest Patents
Lei Shen holds a patent for a predictive biomarker related to hypoxia-activated prodrug therapy. The patent, titled "Predictive biomarker for hypoxia-activated prodrug therapy," indicates that CYP2W1 levels are predictive of the probability that a cancer patient will respond favorably to therapy involving the administration of hypoxia-activated achiral phosphoramidate mustards. This innovation has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Lei Shen is currently employed at Molecular Templates, Inc., where she continues to advance her research in cancer therapy. Her work at the company has positioned her as a key player in the development of novel therapeutic strategies.
Collaborations
Lei collaborates with various professionals in her field, including her coworker Brian A Elenbaas. Their combined expertise contributes to the innovative environment at Molecular Templates, Inc.
Conclusion
In summary, Lei Shen is an influential inventor whose work in predictive biomarkers is paving the way for more effective cancer therapies. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile